?? Making Clinical Trials Accessible: The Importance of Translating Lay Summaries In clinical research, transparency matters. Translating lay summaries ensures that complex trial results are clear and accessible to everyone—fostering trust, meeting regulatory requirements, and empowering patient communities. Read our latest blog to learn best practices for creating impactful, patient-friendly summaries that break down language barriers in healthcare. ???? https://lnkd.in/gyhjMZVi #ClinicalTrials #LaySummaries #PatientEngagement #Translation #LifeSciences
Morningside的动态
最相关的动态
-
Clinical trials serve as the backbone of medical advancements, paving the way for new treatments and therapies to improve human health. Behind every successful trial lies a complex web of logistical challenges and financial considerations. Among these, the often-underestimated aspect of translations plays a pivotal role in ensuring the smooth progression and ultimate success of a trial. #clincialtrials #medicaladvancements #logisticalchallenges #progression #success
要查看或添加评论,请登录
-
Stay informed on the latest in clinical research! Subscribe to the TOTAL Diversity Newsletter for monthly updates on innovations, expert insights, and industry trends shaping the future of clinical trials. Get success stories and key developments delivered right to your inbox. Don’t miss out—be part of the change! ???? Comment below "subscribe," and we’ll reach out to get your email so you won’t miss a thing! #ClinicalResearch #TOTALDiversity #SubscribeNow #InnovationInTrials
要查看或添加评论,请登录
-
-
Expanding clinical trials globally or managing international medical activities? Effective communication is essential. Ensuring accuracy and efficacy in multilingual clinical trials is crucial for reliable results and the global population's health. Read more: https://buff.ly/3Ljq6Lv #ClinicalTrials #MedicalTranslation #PharmaceuticalTranslation #GlobalHealth #EliteAsia
要查看或添加评论,请登录
-
-
Is your evidence generation strategy leaving gaps in your development program? Our new whitepaper by Ramin Farhood, Len Walt, and Dani Thomas challenges the over-reliance on randomized controlled studies. We propose an integrated data strategy that: ??Addresses varied stakeholder requirements ??Enhances chances of program success ??Potentially reduces development costs Are you prepared to meet regulator concerns about patient population relevance and meaningful outcomes? Learn more in our whitepaper 'Driving Therapeutic Impact: A Novel Model for Strategic Medical Affairs Integration'. https://lnkd.in/dYRn9XXu #EvidenceGeneration #ClinicalDevelopment #RegulatoryStrategy
要查看或添加评论,请登录
-
-
For IBP Care Access Brazil and for any Clinical research center - 3 KEY points: “consistent care with protocols avoiding errors, efficient results and good medical assistance ”! #careaccess #clinicresearch #clinicaltrial #innovation #newmedicines
要查看或添加评论,请登录
-
-
Engaging thought leaders in the medical community is now more nuanced. 'Hidden leaders' at regional and local levels play a crucial role in translating high-level medical insights into practical clinical actions. These local advisors, often missed by traditional data analysis, are key to addressing specific challenges faced by their peers and patients: https://bit.ly/4f9EulO
要查看或添加评论,请登录
-
-
Trust is critical in clinical research. But building it can be challenging. In a recent discussion, Kelsey Jakee from PA, along with Rob Goodwin from Pfizer, emphasises the importance of transparent opt-in processes for patient data sharing. Educating patients on how their data will be used is essential for fostering trust and engagement. Let's build a better future together! Watch the full video here https://bit.ly/3V7YfmR to learn how we can create a more patient-centered approach in research. #ClinicalResearch #PatientEngagement
要查看或添加评论,请登录
-
?? Major milestone in UK medical research! ?? The UK’s new clinical trial legislation is here—a bold reform to fast-track approvals, cut red tape, and boost inclusivity. These changes promise faster access to life-saving treatments, more diverse trials that reflect everyone, and stronger global collaboration—all while keeping patient safety at the forefront. We’re proud to support this transformation by helping bridge the gap between trial sponsors and patients with clear, trusted communication. Want the full story? Check out our blog, to explore what this means for researchers, study sites, and most importantly, patients: https://lnkd.in/eDhsccq8
要查看或添加评论,请登录
-
-
Trust is critical in clinical research. But building it can be challenging. In a recent discussion, Kelsey Jakee from PA, along with Rob Goodwin from Pfizer, emphasises the importance of transparent opt-in processes for patient data sharing. Educating patients on how their data will be used is essential for fostering trust and engagement. Let's build a better future together! Watch the full video here https://bit.ly/3V7YfmR to learn how we can create a more patient-centered approach in research. #ClinicalResearch #PatientEngagement
要查看或添加评论,请登录
-
?? Unlock the Future of Decentralized Clinical Trials: Delve Health ?? Our latest white paper,?The Future of Decentralized Clinical Trials, explores the evolution of clinical research and how DCTs are redefining the landscape. Dive into actionable insights and lessons learned to see how we help organizations: ? Break down barriers to patient accessibility ? Harness innovative digital tools for seamless data collection ? Accelerate trial timelines and reduce operational costs ? Put patients at the center with engagement-driven strategies Discover how Delve Health’s expertise and cutting-edge solutions are paving the way for a smarter, more inclusive future in clinical research. ?? Download the white paper today and join us in transforming clinical trials:?https://lnkd.in/gZh7JnEh #DecentralizedClinicalTrials #DCT #DelveHealth #ClinicalResearch #Innovation #PatientCentric
要查看或添加评论,请登录